FP7, a TLR4 antagonist, demonstrated protective effects against influenza virus-induced ALI by reducing proinflammatory cytokines (IL-6, IL-8, and MIP-1β) produced by monocytes and DCs. Here, TLR4 is linked to acute respiratory distress syndrome.